Solutions for Celiac is a clinical trial for celiac disease patients who still experience symptoms despite following a gluten-free diet.
Take CONTROL of celiac disease
GLUTENING HAPPENS.
LET'S DO SOMETHING ABOUT IT.
If you’re having symptoms that you think are caused by gluten, despite being on a gluten-free diet, our clinical trial could be part of the solution for you.
Join the Solutions for Celiac Study, where you get access to:
-
an investigational medication designed to reduce symptoms of accidental gluten cross-contact
-
celiac disease blood testing,
-
symptom reporting tools, and
-
celiac specialists focused on your disease.
Our dedicated study team is led by prominent celiac disease physician-researchers and will work closely with you to track your health related to celiac disease.
Qualifications
You may qualify to participate if you:
-
Are between 18 and 80 years old
-
Have a biopsy confirmed diagnosis of celiac disease
-
Have been on a gluten-free diet for the last 12 months
-
Have experienced at least one moderate or greater severity symptom of abdominal pain and/or bloating in the last month
-
Are not pregnant or actively looking to become pregnant
-
Have no history of drug or alcohol abuse in the last 12 months
-
Are willing to travel to your respective study site for up to 6 visits
Take our pre-screening survey below to find out if you qualify today. For questions or more information, please contact us.
"The goal of this upcoming NIAID-funded study is to understand if latiglutenase reduces symptoms significantly more than placebo in people who are still seropositive while on the gluten-free diet."
Celiac Facts
Approximately 50% of celiac patients are still glutened every day
The average amount of gluten accidentally still eaten on a gluten-free diet is >200 mg/day, and can be up to 36 times the recommended limit! [1]
Serology testing can help diagnose celiac diease.
Serology testing is a specific blood test that determines if your blood contains circulating antibodies to gluten. It is one important element of the celiac disease diagnosis process.
A drink-based study medication taken three times a day with meals.
In a previous study, patients taking latiglutenase 3 times a day with meals experienced 58% and 44% improvement in abdominal pain and bloating, respectively.
